Non-interventional Surveillance of Effectiveness of Symbicort® Maintenance And Reliever Therapy (Symbicort® SMART) in the Treatment of Moderate and Severe Asthma

Real Life Effectiveness in Patients With Not Optimally Controlled Asthma

NCT00784953 ·Status: COMPLETED

Study to Investigate Real Life Effectiveness of Symbicort Maintenance and Reliever Therapy in Asthma Patients Across Asia

NCT00939341 ·Status: COMPLETED ·Phase: PHASE4

A Pharmaceopidemiological Study in Patients Who Use Symbicort SMART

NCT00503061 ·Status: COMPLETED

Real Life Effectiveness in Asthma of Symbicort Single Inhaler Therapy

NCT00319306 ·Status: COMPLETED ·Phase: PHASE3

A 6 Months NIS to Evaluate the Use of Rescue Medication and Quality of Life in Adult Asthmatic Subjects Treated With Symbicort® SMART®

NCT00884689 ·Status: COMPLETED

Study to Investigate the Efficacy of Symbicort® SMART.

NCT00839800 ·Status: COMPLETED ·Phase: PHASE3

Clinical Experience Investigation of Symbicort Turbuhaler as Maintenance Therapy and Reliever Therapy

NCT01711840 ·Status: COMPLETED

Symbicort SMART Satisfaction From Patient Perspective 2009

NCT00946452 ·Status: COMPLETED

Local Phase 4 Pan-European SMART Study

NCT00463866 ·Status: COMPLETED ·Phase: PHASE4

CONCEPT: A 1-Year Comparison Of A Stable Dose Of SERETIDE® Inhaler With An Adjustable Maintenance Dose Of SYMBICORT® Inhaler. SERETIDE® Inhaler is a Trademark of GSK Group of Companies. SYMBICORT® Inhaler is a Trademark of Astra Zeneca.

NCT00479739 ·Status: COMPLETED ·Phase: PHASE4

Symbicort Usage in Asthma Treatment and Impact of a New Therapeutic Strategy on Compliance and Asthma Control in France

NCT00812357 ·Status: COMPLETED

Safety & Efficacy of Symbicort® Turbuhaler® (1, 2, and 4 x 160/4.5 µg Twice Daily) in Japanese Patients With Asthma

NCT00255255 ·Status: COMPLETED ·Phase: PHASE3

Asthma Control-A "Patient Follow up Programme" Maintenance and Reliever Therapy in a Single Inhaler

NCT00524641 ·Status: COMPLETED

Efficacy of Symbicort pMDI Administered Once Daily in Adolescents and Adults During 12 Weeks - STEM

NCT00652392 ·Status: COMPLETED ·Phase: PHASE3

Effect of Symbicort on GR Localisation in Asthma

NCT00159263 ·Status: COMPLETED ·Phase: NA

A Follow-up Survey to Compare Stable Dosing (SERETIDE) With SYMBICORT, SMART, Maintenance and Reliever Therapy in One Inhaler in Moderate and Severe Asthmatics.

NCT00858286 ·Status: COMPLETED ·Phase: PHASE4

Evaluating the Symbicort Turbuhaler (Formoterol/Budesonide) Maintenance and Reliever Therapy for Asthma in Daily Practice

NCT00782314 ·Status: COMPLETED

NIS for Patients Using Symbicort Turbuhaler for Maintenance and Reliever Therapy in a Single Inhaler

NCT00557297 ·Status: COMPLETED

DESOLO - SiT Peri-Launch: A Comparison of Symbicort Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma in Adults

NCT00252863 ·Status: COMPLETED ·Phase: PHASE3

Titratable Dosing in Moderate to Severe Asthmatics

NCT00651768 ·Status: COMPLETED ·Phase: PHASE3

Cross-sectional Study for Identification and Description of Severe Asthma Patients

NCT02293265 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of Safety and Efficacy of Symbicort® pMDI, With or Without Spacer, in Children (6-11 Years) With Asthma

NCT00536913 ·Status: COMPLETED ·Phase: PHASE3

SYMPHONIE - A Comparison of Symbicort Single Inhaler and Conventional Best Practice for the Treatment of Persistent Asthma in Adolescents and Adults

NCT00259792 ·Status: COMPLETED ·Phase: PHASE3

Symbicort Single Inhaler Therapy for Asthma in a General Practice Setting

NCT00235911 ·Status: COMPLETED ·Phase: PHASE3

Real Life Effectiveness in Patients With Not Optimally Controlled Asthma

NCT01647646 ·Status: COMPLETED ·Phase: PHASE4